• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保护还是预防?一个应对新冠疫苗优先排序困境的可行框架。

Protect or prevent? A practicable framework for the dilemmas of COVID-19 vaccine prioritization.

作者信息

Arghal Raghu, Rubin Harvey, Saeedi Bidokhti Shirin, Sarkar Saswati

机构信息

Department of Electrical and Systems Engineering, University of Pennsylvania, Philadelphia, PA, United States of America.

Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, United States of America.

出版信息

PLoS One. 2025 Jan 22;20(1):e0316294. doi: 10.1371/journal.pone.0316294. eCollection 2025.

DOI:10.1371/journal.pone.0316294
PMID:39841676
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11753641/
Abstract

Determining COVID-19 vaccination strategies presents many challenges in light of limited vaccination capacity and the heterogeneity of affected communities. Who should be prioritized for early vaccination when different groups manifest different levels of risks and contact rates? Answering such questions often becomes computationally intractable given that network size can exceed millions. We obtain a framework to compute the optimal vaccination strategy within seconds to minutes from among all strategies, including highly dynamic ones that adjust vaccine allocation as often as required, and even with modest computation resources. We then determine the optimal strategy for a large range of parameter values representative of various US states, countries, and case studies including retirement homes and prisons. The optimal is almost always one of a few candidate strategies, and, even when not, the suboptimality of the best among these candidates is minimal. Further, we find that many commonly deployed vaccination strategies, such as vaccinating the high risk group first, or administering second doses without delay, can often incur higher death rates, hospitalizations, and symptomatic infection counts. Our framework can be easily adapted to future variants or pandemics through appropriate choice of the compartments of the disease and parameters.

摘要

鉴于疫苗接种能力有限以及受影响社区的异质性,确定新冠疫苗接种策略面临诸多挑战。当不同群体表现出不同程度的风险和接触率时,谁应优先尽早接种疫苗?鉴于网络规模可能超过数百万,回答此类问题往往在计算上变得难以处理。我们获得了一个框架,能够在几秒到几分钟内从所有策略中计算出最优接种策略,这些策略包括高度动态的策略,即根据需要随时调整疫苗分配,甚至在计算资源有限的情况下也能做到。然后,我们针对代表美国不同州、不同国家以及包括养老院和监狱在内的各种案例研究的大量参数值,确定了最优策略。最优策略几乎总是少数几个候选策略之一,即便不是,这些候选策略中最佳策略的次优程度也极小。此外,我们发现许多常用的疫苗接种策略,例如先为高风险群体接种,或毫不延迟地接种第二剂,往往会导致更高的死亡率、住院率和有症状感染病例数。通过适当选择疾病的分区和参数,我们的框架可以轻松适用于未来的变种或大流行情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/be51c945aa73/pone.0316294.g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/9cd9d3a59524/pone.0316294.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/4609054843f7/pone.0316294.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/dee87ec5e9d5/pone.0316294.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/c389e4c10010/pone.0316294.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/1bb7a21792e8/pone.0316294.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/72c0a100054a/pone.0316294.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/ef2bc58a38bf/pone.0316294.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/0d09a6326ef9/pone.0316294.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/a452df70ecf2/pone.0316294.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/be10133da156/pone.0316294.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/41643eb753bf/pone.0316294.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/8dfdc7240abf/pone.0316294.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/9cfc6c3ef352/pone.0316294.g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/1f0584f5d139/pone.0316294.g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/be51c945aa73/pone.0316294.g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/9cd9d3a59524/pone.0316294.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/4609054843f7/pone.0316294.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/dee87ec5e9d5/pone.0316294.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/c389e4c10010/pone.0316294.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/1bb7a21792e8/pone.0316294.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/72c0a100054a/pone.0316294.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/ef2bc58a38bf/pone.0316294.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/0d09a6326ef9/pone.0316294.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/a452df70ecf2/pone.0316294.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/be10133da156/pone.0316294.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/41643eb753bf/pone.0316294.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/8dfdc7240abf/pone.0316294.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/9cfc6c3ef352/pone.0316294.g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/1f0584f5d139/pone.0316294.g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515e/11753641/be51c945aa73/pone.0316294.g015.jpg

相似文献

1
Protect or prevent? A practicable framework for the dilemmas of COVID-19 vaccine prioritization.保护还是预防?一个应对新冠疫苗优先排序困境的可行框架。
PLoS One. 2025 Jan 22;20(1):e0316294. doi: 10.1371/journal.pone.0316294. eCollection 2025.
2
Evaluation of the United States COVID-19 vaccine allocation strategy.评估美国 COVID-19 疫苗分配策略。
PLoS One. 2021 Nov 17;16(11):e0259700. doi: 10.1371/journal.pone.0259700. eCollection 2021.
3
Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritization.优化 COVID-19 疫苗在荷兰的分配:基于数据的优先级排序。
PLoS Comput Biol. 2021 Dec 13;17(12):e1009697. doi: 10.1371/journal.pcbi.1009697. eCollection 2021 Dec.
4
Individual preferences for COVID-19 vaccination in China.中国人对 COVID-19 疫苗接种的个体偏好。
Vaccine. 2021 Jan 8;39(2):247-254. doi: 10.1016/j.vaccine.2020.12.009. Epub 2020 Dec 5.
5
Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea.制定大流行 COVID-19 疫苗分配框架:韩国的一项改良德尔菲共识研究。
J Korean Med Sci. 2021 Jun 14;36(23):e166. doi: 10.3346/jkms.2021.36.e166.
6
Evaluation of COVID-19 vaccination strategies with a delayed second dose.评估第二剂接种时间延迟的 COVID-19 疫苗接种策略。
PLoS Biol. 2021 Apr 21;19(4):e3001211. doi: 10.1371/journal.pbio.3001211. eCollection 2021 Apr.
7
Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave.异源疫苗接种干预措施以降低大流行的发病率和死亡率:模拟美国 2020 年冬季 COVID-19 浪潮。
Proc Natl Acad Sci U S A. 2022 Jan 18;119(3). doi: 10.1073/pnas.2025448119.
8
The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.英国新冠病毒疫苗接种与保持社交距离相结合的潜在健康和经济价值:基于传播模型的未来情景分析与经济评估
Lancet Infect Dis. 2021 Jul;21(7):962-974. doi: 10.1016/S1473-3099(21)00079-7. Epub 2021 Mar 18.
9
Development of COVID-19 vaccine policy - United States, 2020-2023.COVID-19 疫苗政策的制定 - 美国,2020-2023 年。
Vaccine. 2024 Sep 17;42 Suppl 3(Suppl 3):125512. doi: 10.1016/j.vaccine.2023.12.022. Epub 2023 Dec 29.
10
mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.mRNA 疫苗诱导的 T 细胞对 SARS-CoV-2 关切变异株的反应完全相同,但根据先前的感染状态,其持久性和归巢特性存在差异。
Elife. 2021 Oct 12;10:e72619. doi: 10.7554/eLife.72619.

本文引用的文献

1
Rural prioritization may increase the impact of COVID-19 vaccines in a representative COVAX AMC country setting due to ongoing internal migration: A modeling study.由于持续的内部迁移,农村优先排序可能会增加新冠疫苗在一个具有代表性的新冠肺炎疫苗实施计划受援国环境中的影响:一项建模研究。
PLOS Glob Public Health. 2022 Jan 27;2(1):e0000053. doi: 10.1371/journal.pgph.0000053. eCollection 2022.
2
COVID-19 Mortality in Adults Aged 65 and Over: United States, 2020.2020 年美国 65 岁及以上成年人的 COVID-19 死亡率。
NCHS Data Brief. 2022 Oct(446):1-8.
3
Optimizing global COVID-19 vaccine allocation: An agent-based computational model of 148 countries.
优化全球 COVID-19 疫苗分配:148 个国家的基于代理的计算模型。
PLoS Comput Biol. 2022 Sep 6;18(9):e1010463. doi: 10.1371/journal.pcbi.1010463. eCollection 2022 Sep.
4
Optimal control of the spatial allocation of COVID-19 vaccines: Italy as a case study.优化 COVID-19 疫苗的空间分配的最优控制:以意大利为例。
PLoS Comput Biol. 2022 Jul 8;18(7):e1010237. doi: 10.1371/journal.pcbi.1010237. eCollection 2022 Jul.
5
COVID-19 prevalence and mortality in longer-term care facilities.长期护理机构中的 COVID-19 患病率和死亡率。
Eur J Epidemiol. 2022 Mar;37(3):227-234. doi: 10.1007/s10654-022-00861-w. Epub 2022 Apr 10.
6
Assessing the best time interval between doses in a two-dose vaccination regimen to reduce the number of deaths in an ongoing epidemic of SARS-CoV-2.评估两剂疫苗接种方案中剂量之间的最佳时间间隔,以减少正在流行的SARS-CoV-2疫情中的死亡人数。
PLoS Comput Biol. 2022 Mar 25;18(3):e1009978. doi: 10.1371/journal.pcbi.1009978. eCollection 2022 Mar.
7
Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19.基于代理的 COVID-19 工作场所和学校反应性疫苗接种建模。
Nat Commun. 2022 Mar 17;13(1):1414. doi: 10.1038/s41467-022-29015-y.
8
Modeling and optimal control of mutated COVID-19 (Delta strain) with imperfect vaccination.不完全接种疫苗情况下变异新冠病毒(德尔塔毒株)的建模与最优控制
Chaos Solitons Fractals. 2022 Mar;156:111825. doi: 10.1016/j.chaos.2022.111825. Epub 2022 Jan 31.
9
Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines.SARS-CoV-2 的奥密克戎变异株:基因组学、传染性,以及对当前 COVID-19 疫苗的反应。
J Med Virol. 2022 May;94(5):1825-1832. doi: 10.1002/jmv.27588. Epub 2022 Jan 23.
10
Mathematical modeling and optimal control of the COVID-19 dynamics.新型冠状病毒肺炎动态的数学建模与最优控制
Results Phys. 2021 Dec;31:105028. doi: 10.1016/j.rinp.2021.105028. Epub 2021 Nov 27.